Evidence map›Paper›PMID 38630793›Full record

ArticleThe British journal of surgery2024

Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma.

Robert C Walker, Jack Harrington, Stella P Breininger, Oliver Pickering, Samuel L Hill, Benjamin P Sharpe, Ben Grace, Ian Reddin, Rushda Rajak, Antigoni Manousopoulou and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Robert C WalkerSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0003-2101-1318
Jack HarringtonSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Stella P BreiningerSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Oliver PickeringSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0003-4100-385X
Samuel L HillSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Benjamin P SharpeSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Ben GraceSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Ian ReddinSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Rushda RajakPathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Antigoni ManousopoulouProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasedena, California, USA.
Spiros D GarbisProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasedena, California, USA.
Zoë S WaltersSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Matthew J J Rose-ZerilliSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Timothy J UnderwoodSchool of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0001-9455-2188
University of Southampton · GBCalifornia Institute of Technology · USUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

Cancer Research UK Advanced Clinician Scientist Fellowship A23924John Goldman Fellowship 2016/JGF/0003Royal College of Surgeons of EnglandSouthampton CRUK Centre Development Fund
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaEsophageal NeoplasmsHumansNeoadjuvant TherapyNeoplasm, Residual

Identifiers

PMID38630793
PMCPMC11023542
OpenAlexW4394870077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.